Kyle Karpinski

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Massachusetts General Hospital(Current)

Harvard University

Dana-Farber Cancer Institute

Brigham and Women's Hospital

Kyle Karpinski is an author at Massachusetts General Hospital specializing in oncology, chimeric antigen receptor t-cell therapy, and therapy response assessment.

ORCID

Publications per year

2023–2024

Publications

Longitudinal patient-reported outcomes in patients receiving chimeric antigen receptor T-cell therapy

P. Connor Johnson, Tejaswini Dhawale, Richard Newcomb et al. · Blood Advances · 2023 · 39 citations · Full text

Medicine, Immunology, Oncology +15

Quality of Life and Prognostic Awareness in Caregivers of Patients Receiving Chimeric Antigen Receptor T Cell Therapy

Anna Barata, Tejaswini Dhawale, Richard Newcomb et al. · Transplantation and Cellular Therapy · 2024 · 13 citations · Full text

Medicine, Immunology, Oncology +12

1–2 of 2